News
2d
Medpage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...
Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...
5h
Futurism on MSNDiabetic Woman No Longer Needs Insulin After Single Dose of Experimental Stem CellsA woman with Type 1 diabetes said her diagnosis felt like a "death sentence" — but with a new stem cell therapy, she's now ...
A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report. The treatment, called zimislecel, was made ...
1h
News-Medical.Net on MSNStress-activated gene damages insulin-producing cells in type 2 diabetesResearchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...
A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...
One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...
10hon MSN
A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...
An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results